Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc.（HARP）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · HARP · 截至 2026年6月9日
活动摘要
买入笔数
9
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Harpoon Therapeutics, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
HARP 季度内部人买卖趋势
HARP 内幕交易卖出 · HARP 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
HARP 高管卖出股份 · HARP 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 11, 2024 | New Leaf Biopharma Opportunities II, L.P. Director | Other | 395,783 | $9.10M⚡ | Form 4 |
| Mar 11, 2024 | SILVERNAIL LAUREN P Director | Other | 5,000 | $115K | Form 4 |
| Mar 8, 2024 | HUNT RONALD Director | Award | 424 | — | Form 4 |
| Mar 11, 2024 | HUNT RONALD Director | Other | 395,783 | $9.10M⚡ | Form 4 |
| Mar 11, 2024 | Walker Luke Nathaniel Chief Medical Officer | Other | 135,000 | $3.10M⚡ | Form 4 |
| Mar 11, 2024 | Myers Scott Dunseth Director | Other | 22,665 | $521K | Form 4 |
| Mar 8, 2024 | Chin Mark Director | Award | 424 | — | Form 4 |
| Mar 11, 2024 | Chin Mark Director | Other | 13,224 | $304K | Form 4 |
| Mar 8, 2024 | DRACHMAN JONATHAN G Director | Award | 415 | — | Form 4 |
| Mar 11, 2024 | DRACHMAN JONATHAN G Director | Other | 5,415 | $125K | Form 4 |
| Mar 11, 2024 | Robbins Andrew R Director | Other | 5,000 | $115K | Form 4 |
| Mar 11, 2024 | Lanza Frank J Principal Fin. & Acctng Ofc. | Other | 18,734 | $431K | Form 4 |
| Mar 11, 2024 | EASTLAND JULIA MARIE President and CEO · Director | Award | 31,250 | — | Form 4 |
| Mar 11, 2024 | EASTLAND JULIA MARIE President and CEO · Director | Other | 269,381 | $6.20M⚡ | Form 4 |
| Mar 11, 2024 | BAILES JOSEPH S Director | Other | 5,000 | $115K | Form 4 |
| Jan 7, 2024 | Walker Luke Nathaniel Chief Medical Officer | Award | 115,000 | — | Form 4 |
| Jan 7, 2024 | Lanza Frank J Principal Fin. & Acctng Ofc. | Award | 15,000 | — | Form 4 |
| Jan 7, 2024 | EASTLAND JULIA MARIE President and CEO · Director | Award | 178,500 | — | Form 4 |
| Jan 1, 2024 | Myers Scott Dunseth Director | Award | 2,048 | — | Form 4 |
| Jan 1, 2024 | HUNT RONALD Director | Award | 1,072 | — | Form 4 |
| Jan 1, 2024 | Chin Mark Director | Award | 1,072 | — | Form 4 |
| Nov 26, 2023 | Walker Luke Nathaniel Chief Medical Officer | Award | 20,000 | — | Form 4 |
| Nov 26, 2023 | Lanza Frank J Principal Fin. & Acctng Ofc. | Award | 2,000 | — | Form 4 |
| Nov 26, 2023 | EASTLAND JULIA MARIE President and CEO · Director | Award | 50,000 | — | Form 4 |
| Nov 27, 2023 | SILVERNAIL LAUREN P Director | Award | 5,000 | — | Form 4 |
New Leaf Biopharma Opportunities II, L.P.
Director
日期
Mar 11
股数
395,783
均价
$23.00
总金额
$9.10M ⚡
Walker Luke Nathaniel
Chief Medical Officer
日期
Mar 11
股数
135,000
均价
$23.00
总金额
$3.10M ⚡
Lanza Frank J
Principal Fin. & Acctng Ofc.
日期
Mar 11
股数
18,734
均价
$23.00
总金额
$431K
EASTLAND JULIA MARIE
President and CEO · Director
日期
Mar 11
股数
269,381
均价
$23.00
总金额
$6.20M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 HARP 内幕交易
HARP 内幕交易
Harpoon Therapeutics, Inc.（HARP）内幕交易数据来源于公司内部人（包括HARP）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。HARP内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Harpoon Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
HARP 内幕交易 · 5个问题Harpoon Therapeutics, Inc.（HARP）的内部人包括高管和董事，如HARP等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026